Real-time enrollment status for this hepatitis c clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06868264 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hepatitis C |
| Phase | Clinical Trial |
| Target Enrollment | 880 participants |
| Active Locations | 88 sites in the US |
| Sponsor | Atea Pharmaceuticals, Inc. |
| Last Updated on CT.gov | December 5, 2025 (Dec 5, 2025) |
As of March 2, 2026: Clinical trial NCT06868264 is currently active_not_recruiting participants. This clinical trial study for hepatitis c is not currently accepting new participants at 88 locations across the United States. The study is sponsored by Atea Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06868264 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 88 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06868264 was last updated Dec 5, 2025 (December 5, 2025). HelloStudys verifies this status automatically.